Related Experiment Video
Updated: Aug 7, 2026
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
[The immunogenetics of ankylosing spondylitis]
1Service de rhumatologie, CHU Jean-Minjoz, boulevard Fleming, 25030 Besançon cedex, France. eric.toussirot@ufc.univ-fcomte.fr
La Revue De Medecine Interne
|June 20, 2006
Summary
Ankylosing spondylitis (AS) involves genetic and environmental factors, with HLA-B27 playing a key role in its complex immune response and physiopathology. Further research is needed to fully understand HLA-B27's direct impact on AS development.
Area of Science:
- Immunogenetics
- Rheumatology
- Molecular Biology
Context:
- Ankylosing spondylitis (AS) is a chronic inflammatory disease affecting the axial skeleton.
- Its exact pathophysiology remains unclear, involving genetic, environmental, and immune system factors.
Purpose:
- To review the immunogenetic aspects of ankylosing spondylitis.
- To explore the role of HLA-B27 and other genetic factors in AS pathogenesis.
- To discuss the contribution of innate and adaptive immunity to AS.
Summary:
- AS exhibits a genetic predisposition, supported by familial and twin studies.
- Strong association exists between AS and HLA-B27, a molecule with unique biochemical properties influencing T cell interactions.
- Innate immunity, including Toll-like receptors, macrophages, and neutrophils, also contributes to AS pathogenesis.
Impact:
- Understanding HLA-B27's molecular structure and function is crucial for elucidating AS pathophysiology.
- This review highlights the complex interplay of genetic and immune factors in AS.
- Further investigation into HLA-B27's specific mechanisms may lead to targeted therapies.
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
00:42Cross-reactivity
Overview